{"title":"Stacks","description":"\u003cp class=\"font-claude-response-body\"\u003e\u003cspan style=\"font-family: 'Arial',sans-serif;\"\u003eThis collection brings together the best peptide stacks Canada-shipped from our catalog — matched-batch research kits combining two or three reference compounds into single supply units. Each stack is built around mechanistic non-overlap.\u003c\/span\u003e\u003c\/p\u003e","products":[{"product_id":"bpc-157-tb-500-stack","title":"Wolverine Stack (BPC-157 + TB-500)","description":"\u003ch2\u003e\u003cb\u003eBPC-157 + TB-500 Stack — The Wolverine Stack Blend\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe Wolverine Stack combines BPC-157 and TB-500 into a single matched-batch research kit for parallel-pathway tissue repair and recovery research designs. This BPC-157 TB-500 stack is built around mechanistic complementarity — BPC-157 engages nitric oxide signaling and VEGFR2-mediated angiogenesis, while TB-500 engages actin cytoskeleton regulation through G-actin sequestration. The two pathways don't overlap, which means research designs can probe both vascular and cytoskeletal mechanisms simultaneously without confounding mechanism-specific effects. Both compounds in the stack ship at ≥99% HPLC purity with mass-spec-verified identity, separate batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Two lyophilized peptides, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg BPC-157 + 10 mg TB-500 (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, both components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (both components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Wolverine Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 TB-500 stack reflects what is now the most common pairing in published soft-tissue repair research with these two peptides. The rationale is mechanistic non-overlap: rather than two compounds acting through the same pathway with redundant effects, BPC-157 and TB-500 engage distinct targets — the former operating through nitric-oxide-pathway and VEGFR2 modulation, the latter through actin-cytoskeleton regulation. Research designs that incorporate both compounds can therefore probe parallel repair pathways in the same model system without confounding mechanism-specific effects.\u003c\/p\u003e\n\u003cp\u003eThe combination also reflects the breadth of the underlying literature. BPC-157 has been characterized in over 100 published animal studies spanning gastrointestinal, musculoskeletal, vascular, and neural injury models. The thymosin β-4 literature spans more than four decades and covers wound healing, cardiac repair, neural regeneration, and inflammation. The Wolverine Stack gives Canadian research groups a single supply point for both reference compounds, with batch-specific certificates of analysis confirming ≥99% HPLC purity for each constituent.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eParallel Repair Pathway Investigation —\u003c\/b\u003e The combination allows research designs to address nitric-oxide-pathway and actin-cytoskeleton mechanisms simultaneously, with each peptide serving as a tool for its respective pathway in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSoft Tissue \u0026amp; Tendon Models —\u003c\/b\u003e Published rodent studies of Achilles tendon transection, medial collateral ligament injury, and muscle crush have characterized BPC-157 and TB-500 effects independently; combined research designs build on both literatures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAngiogenesis \u0026amp; Vascular Remodeling —\u003c\/b\u003e Both peptides have documented pro-angiogenic activity — BPC-157 via VEGFR2 upregulation, TB-500 via endothelial cell migration and capillary network organization — making the stack a focused tool for vascular research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Repair Research —\u003c\/b\u003e Murine ischemia-reperfusion models have separately reported reduced infarct size with TB-500 and improved vascular outcomes with BPC-157, with combined-administration designs appearing in more recent published preclinical work.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eInflammatory Modulation —\u003c\/b\u003e Both compounds have measured effects on cytokine expression and NF-κB signaling in published models, supporting research designs that address tissue repair coupled with inflammatory-pathway endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Wolverine Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring BPC-157 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring TB-500 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/glow-peptide-canada\" title=\"View Glow Stack Product Page\"\u003eGlow Stack\u003c\/a\u003e\u003c\/b\u003e — Adds GHK-Cu to the BPC-157 + TB-500 backbone for research designs extending repair endpoints into ECM remodeling and skin biology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy the BPC-157 TB-500 stack in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Wolverine Stack ships to Canadian research labs and independent investigators with two batch-specific certificates of analysis — one per component — confirming ≥99% HPLC purity and mass-spec identity verification for both BPC-157 and TB-500. Each vial is filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and orders dispatch from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is the Wolverine Stack different from buying BPC-157 and TB-500 separately?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eFunctionally, the contents are identical to single-compound vials of each peptide. The Wolverine Stack format is a packaging convenience for research designs that always use the two compounds together — kit shipping reduces logistics overhead, and matched batch documentation is provided. For research designs that require one compound at a different ratio than the other, or that don't always use both, sourcing each compound individually may be more appropriate.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy are BPC-157 and TB-500 so commonly studied together?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe two peptides act through entirely different molecular mechanisms, which makes their combination useful for parallel pathway investigation rather than redundant pathway coverage. BPC-157 modulates nitric oxide signaling and upregulates VEGFR2-mediated angiogenesis. TB-500 regulates the actin cytoskeleton through G-actin sequestration. In published animal studies of soft-tissue injury, the two compounds appear together more frequently than any other peptide pairing in the repair-research literature.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eAre both peptides naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially, in different ways. BPC-157's 15-amino-acid sequence corresponds to a region of body protective compound, a protein identified in human gastric juice; the synthetic peptide is the isolated fragment. TB-500 is the synthetic full-length sequence of thymosin β-4, an actin-binding peptide endogenous to most mammalian cell types and originally isolated from calf thymic tissue.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️\u003cem\u003e For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg","offer_id":46054364414089,"sku":null,"price":154.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg\/10mg","offer_id":46134481715337,"sku":null,"price":879.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg (one box)","offer_id":46054364446857,"sku":null,"price":1149.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bpc-157-tb-500-wolverine-stack-peptide-canada_standardized_45005065-9a0a-4d37-aaf6-d266514f1b1d.png?v=1778371509"},{"product_id":"glow-peptide-canada","title":"Glow Stack (BPC-157 + TB-500 + GHK-Cu)","description":"\u003ch2\u003e\n\u003cmeta charset=\"utf-8\"\u003eBPC-157 + TB-500 + GHK-Cu Stack — The Glow Stack for Multi-Pathway Research\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eThe Glow Stack combines BPC-157, TB-500, and GHK-Cu into a single matched-batch research kit for multi-pathway dermal repair, ECM remodeling, and tissue-level research designs. Each compound in the BPC-157 TB-500 GHK-Cu stack engages a distinct mechanism — BPC-157 through nitric oxide pathway and VEGFR2-mediated angiogenesis, TB-500 through G-actin sequestration and cellular migration regulation, and GHK-Cu through copper-mediated ECM remodeling and gene expression modulation. The mechanism non-overlap gives research designs three complementary tools in matched documentation. Each component ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Three lyophilized compounds, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003cb\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Glow Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Glow Stack builds on the BPC-157 + TB-500 repair backbone — already the most frequent two-peptide pairing in published soft-tissue research — and adds GHK-Cu to extend the design into ECM remodeling, gene-expression modulation, and skin biology. The rationale is mechanistic stratification: each compound operates through a distinct molecular pathway, so research designs incorporating the full stack can probe parallel mechanisms in the same model system without confounding overlap.\u003c\/p\u003e\n\u003cp\u003eThe combination also reflects the breadth of supporting literature. BPC-157 has over 100 published animal studies across repair domains. The thymosin β-4 literature spans four decades. GHK-Cu's published research arc reaches back to its 1973 isolation from human plasma by Loren Pickart, with subsequent genomic profiling identifying expression changes across roughly 4,000 human genes. The Glow Stack gives Canadian research groups a single supply point for all three reference compounds, with batch-specific certificates of analysis confirming ≥99% HPLC purity for each constituent.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eMulti-Pathway Skin \u0026amp; ECM Research —\u003c\/b\u003e The stack allows research designs to address nitric-oxide-pathway, actin-cytoskeleton, and copper-mediated ECM-remodeling mechanisms simultaneously, giving each compound a defined role in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCollagen \u0026amp; Glycosaminoglycan Synthesis —\u003c\/b\u003e GHK-Cu has documented effects on dermal fibroblast collagen, decorin, and glycosaminoglycan production. Combined with BPC-157 and TB-500's separate repair-pathway activity, the stack covers structural ECM endpoints alongside vascular and cytoskeletal mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eHair Follicle Research —\u003c\/b\u003e GHK-Cu has measured effects on hair follicle morphology and anagen-phase signaling in animal and ex vivo models. Stacked with BPC-157 and TB-500's vascular and cytoskeletal contributions, the combination supports hair-biology research with multiple parallel mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eWound Repair \u0026amp; Re-Epithelialization —\u003c\/b\u003e All three compounds have published activity in rodent wound models — BPC-157 via cytoprotection and angiogenesis, TB-500 via keratinocyte and fibroblast migration, GHK-Cu via fibroblast recruitment and pro-angiogenic gene expression. Combined research designs build on three independent literatures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eGene Expression \u0026amp; Transcriptomic Research —\u003c\/b\u003e GHK-Cu's documented activity across thousands of human genes makes the Glow Stack uniquely suited to research designs combining functional repair endpoints with transcriptomic analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Glow Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring BPC-157 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring TB-500 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring GHK-Cu alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/bpc-157-tb-500-stack\" title=\"View Wolverine Stack Product Page\"\u003eWolverine Stack\u003c\/a\u003e\u003c\/b\u003e — The two-compound BPC-157 + TB-500 backbone, for research designs that don't extend into ECM-remodeling and skin-biology endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhat makes this kit a glow peptide Canada researchers source for skin and ECM work?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThree reasons. First, the published preclinical literature for the constituent compounds — BPC-157, TB-500, and GHK-Cu — covers skin biology, ECM remodeling, hair follicle research, and wound repair across decades of work. Second, the mechanistic stratification across nitric-oxide, cytoskeletal, and copper-mediated ECM pathways gives research designs clean tool separation. Third, sourcing all three compounds as a matched-batch kit shipped from within Canada simplifies documentation and avoids cold-chain interruptions at the border.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is the Glow Stack different from the Wolverine Stack?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe Wolverine Stack is the two-compound BPC-157 + TB-500 repair backbone, focused on soft-tissue and angiogenesis research. The Glow Stack adds GHK-Cu to that backbone, extending the design into ECM remodeling, broad gene-expression modulation, and skin-biology research. Research groups studying tendon, ligament, or muscle repair without dermal endpoints typically work with the Wolverine Stack; groups whose designs include skin, hair, or ECM-remodeling research add GHK-Cu and use the Glow Stack.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy are these three compounds frequently studied together in skin research?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eEach operates through a distinct mechanism with documented activity in dermal and connective-tissue models. BPC-157 contributes cytoprotection and VEGFR2-mediated angiogenesis. TB-500 contributes cellular migration and capillary network formation through G-actin sequestration. GHK-Cu contributes ECM-remodeling, collagen and glycosaminoglycan synthesis, and broad gene-expression modulation through copper-mediated signaling. Combined research designs cover three parallel mechanisms in a single model.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eAre the three compounds naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eIn varying degrees. BPC-157's 15-amino-acid sequence corresponds to a region of body protective compound found in human gastric juice; the synthetic peptide is the isolated fragment. TB-500 is the synthetic full-length sequence of thymosin β-4, endogenous to most mammalian cell types. GHK-Cu is fully endogenous, present in human plasma, saliva, and urine, and released at sites of tissue injury through breakdown of SPARC and type I collagen. The synthetic preparations are sequence-identical to their endogenous forms.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg\/50mg (one vial)","offer_id":46210700640393,"sku":null,"price":164.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg\/10mg\/50mg","offer_id":46210700673161,"sku":null,"price":889.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg\/50mg (one box)","offer_id":46210700705929,"sku":null,"price":1299.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bpc-157-tb-500-ghk-cu-glow-stack-peptide-canada_standardized_2f465125-607f-4157-baaf-dafbcb43a096.png?v=1778371780"},{"product_id":"mots-c-ss31-nad-stack","title":"Mito Stack (MOTS-c + SS-31 + NAD+)","description":"\u003ch2\u003e\u003cb\u003eMOTS-c + SS-31 + NAD+ Stack — The Mito Stack Blend\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe Mito Stack combines MOTS-c, SS-31, and NAD+ into a single matched-batch research kit for three-layer mitochondrial bioenergetics research designs. This MOTS-c SS-31 NAD+ stack addresses mitochondrial biology at three distinct levels — MOTS-c provides signaling-layer intervention through AMPK activation, SS-31 provides structural-layer intervention through cardiolipin binding and cristae stabilization, and NAD+ provides biochemical-layer intervention as the cofactor underlying sirtuin signaling and electron transport chain operation. All three compounds in the stack ship at ≥99% HPLC purity with mass-spec-verified identity, separate batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Three lyophilized compounds, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg MOTS-c + 10 mg SS-31 + 600 mg NAD+ (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light; long-term NAD+ storage at −20 °C\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Mito Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe MOTS-c SS-31 NAD+ stack reflects a deliberate stratification across the three principal layers of mitochondrial biology that researchers commonly investigate. MOTS-c addresses the signaling layer — communicating bioenergetic status from mitochondria to the nucleus and activating AMPK as a master energy-sensing kinase. SS-31 addresses the structural layer — binding cardiolipin on the inner mitochondrial membrane and stabilizing cristae morphology in compromised mitochondria. NAD+ addresses the biochemical layer — cycling between oxidized and reduced forms in redox reactions and serving as a consumed substrate for sirtuins, PARPs, and CD38.\u003c\/p\u003e\n\u003cp\u003eThis three-layer separation gives research groups clean mechanistic resolution. Rather than three compounds with overlapping modes of action, each operates at a distinct level of mitochondrial biology, allowing experimental designs to probe signaling, structural, and cofactor contributions in the same model system. The combination matches the modern mitochondrial-research literature, where studies frequently address all three layers simultaneously to characterize bioenergetic phenotypes in aging, metabolic, and cardiac models. As a longevity peptide stack Canada-shipped from a single supply point with matched batch documentation, the Mito Stack simplifies the documentation chain for laboratories operating under quality-control protocols.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eThree-Layer Mitochondrial Investigation —\u003c\/b\u003e The combination allows research designs to address signaling (MOTS-c \/ AMPK), structural (SS-31 \/ cardiolipin), and biochemical (NAD+ \/ redox and sirtuin) mechanisms simultaneously, with each compound serving a distinct role in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAging \u0026amp; Longevity Research —\u003c\/b\u003e All three compounds connect to age-associated mitochondrial decline. MOTS-c plasma levels decline with age in published human and animal data. SS-31 has been studied in aged-rodent skeletal muscle and cardiac models. NAD+ tissue levels decline progressively with age. Combined research designs build on three independent literatures within longevity research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Bioenergetics —\u003c\/b\u003e Rodent ischemia-reperfusion models have separately characterized SS-31's effects on infarct size and mitochondrial respiration. NAD+ has been examined in heart failure and cardiometabolic models. MOTS-c has been studied for metabolic effects relevant to cardiac substrate handling. The stack supports research designs combining all three.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eInsulin Sensitivity \u0026amp; Metabolic Models —\u003c\/b\u003e MOTS-c activates AMPK to improve skeletal muscle glucose uptake. SS-31 has been characterized in type 2 diabetes models for effects on oxidative stress and ER stress. NAD+ has documented effects in rodent obesity and NAFLD models. The combination addresses metabolic dysfunction from three angles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eReactive Oxygen Species \u0026amp; Redox Biology —\u003c\/b\u003e SS-31 reduces mitochondrial ROS production via cardiolipin binding. NAD+ governs cellular redox state through NAD+\/NADH cycling. MOTS-c has been characterized for effects on antioxidant pathways through AMPK-mediated transcription. Combined research designs cover redox biology across structural and biochemical layers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Mito Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring MOTS-c alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-ss-31\" title=\"View SS-31 Product Page\"\u003eSS-31\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring SS-31 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/nad-plus\" title=\"View NAD+ Product Page\"\u003eNAD+\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring NAD+ alone or at non-stack ratios.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy the MOTS-c SS-31 NAD+ stack in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Mito Stack ships to Canadian research labs and independent investigators with three batch-specific certificates of analysis — one per component — confirming ≥99% HPLC purity and mass-spec identity verification for MOTS-c, SS-31, and NAD+. Each vial is filled to approximately 104% of label as a quality margin for residual losses during reconstitution work, and orders dispatch from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow are MOTS-c, SS-31, and NAD+ different from each other mechanistically?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eMOTS-c is a 16-amino-acid mitochondria-derived peptide that activates AMPK and acts as a signaling molecule between mitochondria and the nucleus — a regulatory mechanism. SS-31 is a synthetic tetrapeptide that binds cardiolipin on the inner mitochondrial membrane to stabilize cristae structure and reduce ROS production — a structural mechanism. NAD+ is a pyridine dinucleotide coenzyme that participates in redox cycling and serves as a consumed substrate for sirtuins, PARPs, and CD38 — a biochemical mechanism. The three compounds operate at different levels of mitochondrial biology.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy combine these three compounds in a single research kit?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe combination matches how mitochondrial-research designs are typically structured. Studies of mitochondrial dysfunction in aging, cardiac disease, metabolic syndrome, and neurodegeneration often address signaling, structural, and biochemical layers simultaneously — because dysfunction at one layer typically propagates to the others. A single kit gives research groups all three reference compounds with matched batch documentation, simplifying experimental designs that probe parallel mechanisms.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs NAD+ a peptide?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. NAD+ is a pyridine dinucleotide coenzyme — two nucleotides linked through their phosphate groups, not assembled from amino acids. It is included in the Mito Stack and catalogued alongside research peptides because of its central role in mitochondrial bioenergetics and its frequent appearance in research designs alongside MOTS-c and SS-31. Many suppliers serving the mitochondrial research domain carry both peptide and non-peptide compounds in this category.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg\/600mg (one vial)","offer_id":46211113713801,"sku":null,"price":164.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg\/10mg\/600mg","offer_id":46211113746569,"sku":null,"price":899.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg\/600mg (one box)","offer_id":46211113779337,"sku":null,"price":1369.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/mots-c-ss-31-nad_-mito-stack-peptide-canada_standardized_7a60a455-0cdf-4180-aa0a-b728c3f5e20c.png?v=1778371936"}],"url":"https:\/\/emeraldpeptides.ca\/collections\/best-peptide-stacks-canada.oembed","provider":"Emerald Peptides","version":"1.0","type":"link"}